Slc13a3tm1c(KOMP)Wtsi
Targeted Allele Detail
|
Symbol: |
Slc13a3tm1c(KOMP)Wtsi |
Name: |
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3; targeted mutation 1a, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:7660528 |
Synonyms: |
Slc13a3flox |
Gene: |
Slc13a3 Location: Chr2:165247215-165315117 bp, - strand Genetic Position: Chr2, 85.54 cM, cytoband H3
|
Alliance: |
Slc13a3tm1c(KOMP)Wtsi page
|
|
Mutant Cell Line: |
EPD0110_2_E02 |
Germline Transmission: |
Earliest citation of germline transmission:
J:349783
|
Parent Cell Line: |
JM8.F6 (ES Cell)
|
Strain of Origin: |
C57BL/6N
|
|
Allele Type: |
|
Targeted (Conditional ready) |
Mutation: |
|
Insertion
Vector: L1L2_Bact_P
|
|
|
Mutation details: The L1L2_Bact_P cassette was inserted at position 165287182 of Chromosome 2 upstream of the critical exon(s) (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. A third loxP site is inserted downstream of the targeted exon(s) at position 165288050. The critical exon(s) is/are thus flanked by loxP sites. The lacZ and neomycin resistance gene were deleted via flp-mediated recombination creating a conditional ready floxed allele.
(J:349783)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Slc13a3 Mutation: |
34 strains or lines available
|
|
Original: |
J:349783 Hull VL, et al., Astroglial conditional Slc13a3 knockout is therapeutic in murine Canavan leukodystrophy. Ann Clin Transl Neurol. 2024 Apr;11(4):1059-1062 |
All: |
1 reference(s) |
|